WO2007097357A1 - 揮発性硫化物類の生成抑制剤とこれを利用する揮発性硫化物類の生成抑制方法 - Google Patents
揮発性硫化物類の生成抑制剤とこれを利用する揮発性硫化物類の生成抑制方法 Download PDFInfo
- Publication number
- WO2007097357A1 WO2007097357A1 PCT/JP2007/053173 JP2007053173W WO2007097357A1 WO 2007097357 A1 WO2007097357 A1 WO 2007097357A1 JP 2007053173 W JP2007053173 W JP 2007053173W WO 2007097357 A1 WO2007097357 A1 WO 2007097357A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- volatile
- ascorbic acid
- inhibitor
- formation
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B11/00—Preservation of milk or dairy products
- A23B11/10—Preservation of milk or milk preparations
- A23B11/18—Preservation of milk or milk preparations by addition of preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/779—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B4/00—Preservation of meat, sausages, fish or fish products
- A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
- A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
- A23B4/20—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B5/00—Preservation of eggs or egg products
- A23B5/08—Preserving with chemicals
- A23B5/12—Preserving with chemicals in the form of liquids or solids
- A23B5/14—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B9/00—Preservation of edible seeds, e.g. cereals
- A23B9/16—Preserving with chemicals
- A23B9/24—Preserving with chemicals in the form of liquids or solids
- A23B9/26—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/428—Addition of flavours, spices, colours, amino acids or their salts, peptides, vitamins, yeast extract or autolysate, nucleic acid or derivatives, organic acidifying agents or their salts or acidogens, sweeteners, e.g. sugars or sugar alcohols; Addition of alcohol-containing products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/60—Salad dressings; Mayonnaise; Ketchup
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Definitions
- the present invention relates to ⁇ -D-darcopyranosyl mono (1 ⁇ 2) -L-ascorbic acid (hereinafter referred to as “ascorbic acid”) which is bound to L-ascorbic acid (hereinafter referred to as “ascorbic acid”) by ⁇ -1 and 2 bonds.
- ascorbic acid L-ascorbic acid
- the composition of a volatile sulfide formation inhibitor containing “ascorbic acid 2-darcoside”) as an active ingredient and the volatile sulfide formation inhibitor is incorporated into the composition.
- the present invention relates to a method for suppressing the generation of volatile sulfides, characterized by suppressing the generation of volatile sulfides.
- compositions such as foods and drinks, cosmetics, quasi drugs, pharmaceuticals, and chemical industrial products generate unique volatile substances during the manufacturing process and during storage, and thus have a unique flavor. Although it occurs, it may cause a change in flavor or quality degradation in some cases.
- volatile sulfides can cause discomfort even in trace amounts, and this is one of the major factors that influence the preference of the composition, thus suppressing the generation of volatile sulfides. This has been a very important issue for those skilled in the art.
- the diversification of eating habits and there is a need for a method that suppresses the generation of new volatile sulfides corresponding to the diversification.
- Ascorbic acid has a function as vitamin C and uses its strong, reducing and antioxidant properties to protect other oxidizable substances and compositions from oxidation, and to decompose browning. It is also used for the purpose of suppression. However, ascorbic acid is also known to react with amino acids, peptides, proteins, etc., and in some cases enhance browning and the accompanying generation of volatile substances. On the other hand, ascorbic acid 2-darcoside, an ascorbic acid derivative, is less susceptible to acid oxidization compared to ascorbic acid and is stable, and even when added to the composition, it has a strange odor due to browning.
- ascorbic acid 2-darcoside may even enhance volatile substances depending on its usage.
- ascorbic acid ascorbic acid 2-darcoside is a strong acidic substance, so when used in the composition, the original flavor of the composition is reduced due to its own acidity and neutralizing agent used to reduce the acidity. May be affected.
- the present invention relates to the establishment of a volatile sulfide generation inhibitor capable of suppressing the formation of volatile sulfides from a composition, and the volatile sulfides from a composition using the same. It is an object to provide a method for suppressing the generation of selenium.
- the present inventors have conducted intensive research focusing on ascorbic acid derivatives with the aim of establishing a production inhibitor of volatile sulfides in the composition.
- the ascorbic acid 2-darcoside which has been shown to be surprisingly non-reducing and anti-acid repulsive, but even to enhance the production of volatile substances, has been incorporated. It has been found that when blended into a composition, it is different from ascorbic acid or stronger than ascorbic acid and exhibits an excellent function of suppressing the formation of volatile sulfides of the composition.
- the ascorbic acid 2-darcoside has a compositional power-inhibiting effect on the formation of volatile sulfur-containing compounds, even if it is added to the composition, the original flavor of the composition is not impaired.
- the present invention has been completed by finding that it can be exerted within a very small amount. That is, the present invention relates to volatile sulfates containing ascorbic acid 2-darcoside as an active ingredient.
- the present invention solves the above-mentioned problems by providing a production inhibitor and a method for inhibiting the production of volatile sulfides in the composition, which is incorporated into the composition.
- the production of volatile sulfides during the production process and during storage is suppressed, and food and drink, cosmetics, quasi-drugs, pharmaceuticals, feeds, and feeds that retain flavor and quality.
- a composition such as a pet food can be produced.
- a composition containing this ascorbic acid 2-darcoside is taken orally or parenterally, applied to the skin, or administered to a living body by injection or the like. Since it is decomposed by ⁇ -darcosidase and converted to ascorbic acid and glucose, it is an excellent inhibitor of the production of volatile sulfur compounds from the viewpoint of safety.
- composition referred to in the present invention is a liquid, semi-solid or solid form containing a sulfur-containing amino acid or a sulfur-containing compound such as a peptide containing the same, which generates a volatile sulfide by heating or long-term storage.
- Compositions such as foods and drinks, cosmetics, quasi drugs, pharmaceuticals, feeds, feeds, pet foods, miscellaneous goods, daily necessities, etc. for humans or animals that are ingested orally or parenterally Directly used, including those administered parenterally by injection or the like.
- the volatile sulfur compounds referred to in the present invention are volatile sulfides generated during the production process and storage of the composition, and the generation thereof causes a decrease in the flavor and quality of the composition. Or those contained in bad breath and body odor, specifically hydrogen sulfide, methyl mercaptan, dimethylsulfide, dimethyldisulfide and the like.
- the volatile sulfide production inhibitor of the present invention is particularly excellent in suppressing the production of hydrogen sulfide, dimethyl sulfide, and soot or dimethyl disulfide among these volatile sulfides.
- the production inhibitor of volatile sulfurous substances referred to in the present invention is an amount capable of suppressing the production of volatile sulfurous substances from the composition when it is contained in the composition. It should contain ascorbic acid 2-darcoside.
- the form may be a single agent of ascorbic acid 2-darcoside, and if necessary, it may be formulated pharmacologically according to the purpose of use, such as increasing dispersibility, dilution, shaping, or stabilization. It is also optional to add one or more of the acceptable formulation additives.
- the proportion of ascorbic acid 2 darcoside in the inhibitor for the formation of volatile sulfides is 0.1% by mass to 100% by mass with respect to the total mass of the inhibitor. (Hereinafter, unless otherwise specified, “mass%” is simply expressed as “%”.) 1% to 100% is desirable, and 5% to 100% is particularly desirable.
- the formulation additive that can be used as the volatile sulfur-containing product inhibitor in the present invention can be used in the fields of food, cosmetics, quasi-drugs, pharmaceuticals, miscellaneous goods, etc.
- reducing sugars such as glucose and maltose, a, ⁇ -trehalose, a-gnorecosinole a, a-trenosylose and a-manoletosinore a, a-trenosulose ⁇ , ⁇ -Carbohydrate derivative of trehalose, cyclo as described in the specification of WO 02Z10361, etc.
- Sugar alcohol high-intensity sweetener, gums, water-soluble polymers including polysaccharides, inorganic acids, organic acids, salts, emulsifiers, vitamin E, erythorbic acid, catechins, chlorogenic acid, flavonoids and these Derivatives of the above, amino acids containing carcin, adenosine and its phosphate, ⁇ -lipoic acid, Coenzyme Q10 (CoQ10), or one or more can be used.
- CoQ10 Coenzyme Q10
- One or two or more types of stoppers can be used in combination, including non-reducing carbohydrates, sugar alcohols, vitamin E, catechins, flavonoids and their derivatives, lactic acid, acetic acid, Combining one or two or more organic acids such as citrate and inorganic salts can enhance the inhibitory effect of ascorbic acid 2-darcoside on the formation of volatile sulfates.
- ⁇ , ⁇ trehalose, maltitol, carbohydrate derivatives of ⁇ , ⁇ -trehalose and cyclic tetrasaccharides have strong inhibitory effects on the formation of volatile sulfides, and are therefore one of these substances. Or it is desirable to combine two or more.
- Ascorbic acid 2 dalcoside for use as a production inhibitor for volatile sulfur compounds of the present invention May be produced by fermentation, enzyme, organic synthesis, etc., with no restrictions on its origin or production method, and it is also optional to purchase and use Ruascorbic acid 2-Dalcoside. It is.
- an ascorbic acid is obtained by allowing an ⁇ -glycosyltransferase such as cyclomaltodextrin glucanotransferase to act on a mixed solution of ascorbic acid and starch such as dextrin. Glycosylate, partially purified, or further purified using ion-exchange resin, etc.
- a purified ascorbic acid 2-glycoside containing ascorbic acid 2-darcoside bound in an equimolar amount or more is also optional to use. Furthermore, by reacting a composition containing an ascorbic acid 2-glycoside containing ascorbic acid 2-glycoside with darcoamylase or the like, ascorbic acid 2-containing two or more glucose molecules per coexisting ascorbic acid molecule. Glycoside glucose is cleaved and purified to further increase the content of ascorbic acid 2-dalcoside with one glucose molecule bound to one molecule of ascorbic acid. This is particularly desirable because of the low mixing of substances.
- Ascorbic acid 2-darcoside used in the volatile sulfide generation inhibitor of the present invention is preferably one containing 90% or more of ascorbic acid 2-darcoside in terms of solid matter, and 95%
- the above is more desirable, with 97% or more being especially desirable. It also has high reactivity with ascorbic acid such as vitamins and high concentrations of active ingredients such as cosmetics, quasi-drugs and pharmaceuticals, and ingredients that easily cause Maillard reactions such as amino acids and proteins.
- a crystalline product having ascorbic acid 2-darcoside purity of 98% or more is particularly desirable.
- the amount of ascorbic acid 2-darcoside in combination with the total mass of the composition is not particularly limited. Usually, about 0.0005% to 0.5%, preferably about 0.005%. It is preferable that the content is from 001% to 0.1%, and more desirably from about 0.005% to 0.1%.
- the blending amount with respect to the total mass of the composition is less than 0.0005%, the effect of suppressing the formation of volatile sulfides will not be exhibited, and if more than 0.5%, the volatile sulfides will not be exhibited. May enhance the production of the product and may affect the taste quality of the composition.
- the purpose is to suppress the formation of dimethyl sulfide and Z or dimethyl disulfide, and the composition has a sour taste, it does not affect the taste quality of the composition.
- ascorbic acid 2-darcoside is optionally added in an amount of 0.5% or more based on the total mass of the composition.
- the volatile sulfide generation inhibitor to be contained in the composition is not limited in its shape, and may be any shape such as syrup, mass kit, paste, powder, solid, granule, tablet, etc. However, it can be used as it is or, if necessary, mixed with fillers, excipients, binders, etc., and molded into various shapes such as granules, spheres, short bars, plates, cubes, tablets, etc. It is also optional to use.
- the volatile sulfur product formation inhibitor of the present invention is a specific method that can be contained in the process until the target composition is completed or in the finished product. Examples include admixture, kneading, dissolution, melting, dispersion, suspension, emulsification, penetration, crystallization, spraying, application, adhesion, spraying, coating (coating), pouring, dipping, solidification, reverse micelles. A combination of one kind or two or more kinds of methods is appropriately selected.
- the method for suppressing the formation of volatile sulfides according to the present invention is a high-quality, for example, seasonings, sweeteners, Japanese confectionery, Western confectionery that suppresses the formation of volatile sulfides.
- Breads, snacks, agricultural products, livestock products, marine products and processed products thereof, frozen products, refrigerated products, chilled products, retort products, dried products, freeze-dried products, range food products, and more can be advantageously used in the production of compositions including food and drink such as soft drinks and alcoholic drinks.
- the present invention also provides high-quality cosmetics and pharmaceuticals, such as feeds, feeds, pet foods, and luxury products, basic cosmetics, and makeup cosmetics, which suppress the generation of volatile sulfides. It can also be advantageously used in the manufacture of quasi-drugs, tablets, liquids, ointments, nutrients, infusion solutions, dialysis solutions, perfusion solutions, organ preservation solutions, and other pharmaceutical products. Furthermore, the method of the present invention is used for the purpose of suppressing the production of volatile hydrogen sulfide in the mouth, the body surface of human animals, the digestive tract, animal excrement, buildings, etc. It can also be used for oral care cosmetics, body care cosmetics, skin care cosmetics, hair care cosmetics and deodorants.
- Ascorbic acid 2-dalcoside (reagent grade, sold by Hayashibara Biochemical Laboratories Co., Ltd.) was dissolved in distilled water to prepare a 10% strength solution. Put a suitable amount of this solution and 5 ml of 500 mM phosphate buffer ( ⁇ 7.0) into a volumetric flask, add distilled water, fill up to 50 ml, and double the concentration of ascorbic acid 2-darcoside as shown in Table 1. Each concentration solution was prepared as a test solution. A test solution containing ascorbic acid was prepared in exactly the same manner except that ascorbic acid (reagent grade) was used instead of ascorbic acid 2-dalcoside.
- a control solution was prepared by adding distilled water to 5 ml of 50 OmM phosphate buffer (pH 7.0) and filling up to 50 ml.
- the edible portion other than the bone and skin of the commercially available mackerel fillet was placed on a trio blender and then stirred evenly to prepare a mackerel mince.
- 45 g of this mackerel meat was collected in a beaker, and 45 g of either the test solution or the control solution was added to adjust the concentration of ascorbic acid 2-dalcoside or ascorbic acid to the concentrations shown in Table 1.
- the test sample was a homogenate prepared using an IKA homogenizer while the sample was ice-cooled. The pH of these homogenates was 6.21 to 6.38.
- the amount of hydrogen sulfide produced per lg of mackerel meat when the control solution was added was defined as 100, and the relative value of the amount of hydrogen sulfide produced when the test solution was added was obtained, and the 100 force was also reduced. Is also shown in Table 1 as the hydrogen sulfide production inhibition rate (%).
- Hydrogen sulfide production amount Hydrogen sulfide production Add to test sample In test sample ( ⁇ gZg mackerel meat) Addition inhibition rate (%), and then adjust to V2 ⁇ , ⁇ JI KO "1-", NO JA 1 ⁇ 111 " ⁇ Concentration of substance (%)
- ascorbic acid 2-darcoside has a concentration of 0.
- concentration of 0. In the range of 0005% to 0.5%, the production of hydrogen sulfide from mackerel meat homogenate was suppressed as compared with the control, and conversely, the concentration of 1.0% enhanced the production of hydrogen sulfide.
- the degree of inhibition was stronger when the ascorbic acid 2-darcoside concentration was lower and stronger.
- concentration in the test sample when ascorbic acid was added, when the concentration in the test sample was 0.005% or less, although the degree of hydrogen sulfate formation was not significantly different from the control, The addition of 0.01% or more enhanced the production.
- ascorbic acid 2-darcoside unlike ascorbic acid, is added in an amount of 0.0005% to 0.5% with respect to the total mass of the composition. It is useful as a hydrogen sulfide production inhibitor that suppresses the production of hydrogen sulfide in water, and it is more desirable to add calorie to 0.001% to 0.1%. ⁇ 0.1% indicate particularly desirable ⁇ Experiment 2: Effect of ascorbic acid 2-darcoside on the formation of dimethylsulfide and dimethyldisulfide>
- Ascorbic acid 2-Dalcoside (reagent grade, sold by Hayashibara Biochemical Laboratories Co., Ltd.) is marketed to the concentration shown in Table 2.
- Ascorbic acid 2-Dalcoside (reagent grade, sold by Hayashibara Biochemical Laboratories Co., Ltd.) is marketed to the concentration shown in Table 2.
- a test solution containing ascorbic acid was prepared in exactly the same manner except that ascorbic acid (reagent grade) was used instead of ascorbic acid 2-glucoside.
- As a control solution commercially available milk was used as it was.
- the amounts of dimethylsulfide and dimethyldisulfide obtained are shown in Table 2 with the amount of gas chromatography produced by a conventional method, and the sum of them is shown in Table 2 as the amount of volatile sulfide produced. Also, assuming that the amount of volatile sulfate produced per 1 ml of the control solution (milk) is 100, the relative value of the amount of volatile sulfate produced per 1 ml of the test solution is obtained, and the value obtained by subtracting from 100 is volatile. It is also shown in Table 2 as the sulfide production inhibition rate (%).
- ascorbic acid 2 dalcodo and ascorbic acid both affect the taste quality of the control solution (milk) at a concentration of 2.5%, but at a concentration of 0.5% or less, It was evaluated that it does not affect the taste of milk.
- control solution milk
- ascorbic acid 2-darcoside is added from 0.505% to 0.5% with respect to the total mass of the composition, so that ascorbic acid does not affect the taste quality of the composition.
- Is also useful as a volatile sulfur production inhibitor because it effectively suppresses the formation of volatile sulfides from the composition. From the standpoint of its effect, 0.005% to It is especially desirable to add 0.5%.
- Ascorbic acid 2-Dalcoside (Sold by Hayashibara Shoji Co., Ltd., trade name “Asco Fresh”) 15 parts by mass, Sodium carbonate 4 parts by weight, hydrous crystals a, a- Trehalose (Selling Hayashibara Shoji, trade name “Treha”) 81 parts by mass were homogeneously mixed to prepare a powdery volatile sulfide formation inhibitor.
- This product can be advantageously used as an inhibitor of the formation of volatile sulfides in compositions including food and drink.
- Ascorbic acid 2-Dalcoside (trade name “AA2 G”, sold by Hayashibara Biochemical Research Co., Ltd.) 10 parts by weight and 5 parts by weight of sodium carbonate are dissolved in 200 parts by weight of water, and syrup (X, a trehalose is added to this.
- Carbohydrates containing saccharide derivatives (sales by Hayashibara Shoji Co., Ltd., trade name “NO, Rhodettas”, solid content 72%) Dissolve 120 parts by mass, spray-dry by conventional methods, and form powdered volatile sulfides
- This product can be advantageously used as a production inhibitor of volatile sulfur in compositions such as foods and drinks.
- ⁇ Production inhibitor of volatile sulfur compounds > Ascorbic acid 2-Dalcoside (trade name “AA2 G”, sold by Hayashibara Biochemical Laboratories, Inc.), 20 parts by mass, cyclo ( ⁇ 6)-a—D—Dalcopyranosyl (1 ⁇ 3)-a— D—Glucopyranosyl 1 (1 ⁇ 6)-a-D-Darkopyranosyl 1 (1 ⁇ 3)-a- D-Darkopyranosyl (1 ⁇ cyclic tetrasaccharide (manufactured by Hayashibara Biochemical Research Institute, Inc.) 70 parts by mass, Glycosyl hesperidin (Hayashibara Shoji Co., Ltd., trade name “Hayashibara Darcosyl Hesperidin S”) 10 parts by mass were homogeneously mixed to prepare a powdery volatile sulfide formation inhibitor. It can be advantageously used as an inhibitor for the formation of volatile sulfates in compositions such as
- an aqueous solution in which the production inhibitor of powdered volatile sulfur products obtained by the method of Example 1 was dissolved to 1% was prepared.
- the bonito was produced in a conventional manner except that it was used as a broth. Since this product contains the volatile sulfide production inhibitor of the present invention, the volatile sulfides accompanying protein denaturation of sulfur-containing amino acids after storage for 6 months at room temperature. The formation of volatile aldehydes and volatile amines caused by lipid oxidation and decomposition is also suppressed, and the potato has a favorable taste of bonito without excessive drying. Flavors such as aroma, color and texture were good, and the strength was stable for a long time.
- This bonito is stored at room temperature for 6 months after production, then shaved with a bonito shaver, heated by adding 500 parts by weight of water to 100 parts by weight, boiled for 5 minutes, and then cooled.
- a bonito extract was prepared. This extract had the same preferred taste and fragrance as those using bonito just after production.
- Example 2 Powdered volatile sulfides formation inhibitor obtained by the above method was added by 0.05 parts by mass, stirred and dissolved, and spray-dried by a conventional method to prepare powdered dashi.
- This product has suppressed the generation of volatile sulfides, and also suppressed the generation of volatile aldehydes and volatile amines caused by the decomposition of citrus and lipid acids.
- Preferred powder with taste and aroma Because it is excellent in storage stability such as keeping the fluidity immediately after manufacturing without being caked, it can be used alone, or in combination with other extracts, in powder, liquid, solid, It is suitable as a raw material for producing a steep dashi seasoning.
- the powdery volatile sulfide generation inhibitor obtained by the method of Example 1 was diluted 1000 times with water so that the salt was 0.8% and sodium lactate was 0.1%.
- the soaking solution was prepared by addition, and a fresh sea urchin ovary was placed in a sieve and immersed. After 10 hours at 5 ° C, the sieve was raised and drained to obtain a product.
- This product generates almost no volatile sulfur compounds such as hydrogen sulfide ketyl mercabtan, and also suppresses the generation of volatile aldehydes and volatile amines caused by lipid oxidation and decomposition.
- the plate was shaped into approximately 120 g pieces and steamed so that the internal product temperature was about 80 ° C. in 30 minutes. And leave it at 4 ° C for 24 hours to obtain a fish paste product.
- the formation of volatile sulfides is suppressed by ascorbic acid 2-darcoside, and the formation of volatile aldehydes and volatile amines caused by acid digestion of lipids is also suppressed.
- This product is also characterized by excellent storage stability, and even after thawing after freezing, it retains its preferred flavor, fragrance, color, texture, etc. immediately after preparation. Has been.
- Bacon was prepared by injecting 1 part by weight of pickle liquid into 9 parts by weight of pork fillet over a period of time so that it could evenly penetrate the whole meat and then smoked in a conventional manner. After smoked, it was left at room temperature overnight, and the sliced bacon was vacuum-packed and stored at 10 ° C. This product also suppresses the formation of volatile sulfides even after 1 week of storage, and also suppresses the formation of volatile aldehydes and volatile amines produced by the acid degradation of lipids. The flavor immediately after production was well preserved, and even after thawing after freezing, the flavor was good.
- vinegar 10 parts by weight of vinegar, 7.5 parts by weight of powdered maltitol, 8 parts by weight of sterilized whole egg, 6 parts by weight of water, 2 parts by weight of salt, 0.5 parts by weight of sugar, 0.5 parts by weight of flour, 0.5 part by weight of sodium glutamate 0 .5 parts by weight, ascorbic acid 2-Dalcoside (Hayashibara Shoji Co., Ltd., trade name “Ascofuresh”) 0.005 parts by mass, and further 45 parts by weight of salad oil were added and emulsified in the usual way.
- a mayonnaise-like food was prepared.
- This product has the same mouthfeel as mayonnaise, and this product has ascorbic acid 2-dalcoside and maltitol to suppress the formation of volatile sulfur compounds, and to further degrade lipids.
- the generation of volatile aldehydes and volatile amines generated by the above is also suppressed, and the separation of fats and oils is suppressed, so that the quality is stable even at room temperature, chilled, refrigerated or frozen for a long period of time. Retained.
- Milk was prepared by dissolving 0.01 parts by mass of the powdery sulfur-containing product inhibitor obtained by the method of Example 1 with respect to 100 parts by mass of fresh milk. Even when heated, this product suppresses the formation of volatile sulfides, including hydrogen sulfide, and maintains the favorable taste and aroma of milk that does not cause off-flavors. Alternatively, it is advantageously used as a raw material for milk drinks and milk drinks. Can be used.
- this product contains a, ⁇ -trehalose, a, ⁇ -Since it contains a sugar derivative of trehalose, the generation of volatile sulfur compounds such as hydrogen sulfide, dimethylsulfide, and dimethyldisulfide during heating is suppressed, and there is no generation of off-flavors. Even after freezing, the appearance and flavor immediately after production can be retained. Moreover, baked goods such as confectionery of this product use is also at the time of firing, as well, since the formation of volatile vulcanization I ⁇ such a custard can be suppressed, and excellent in flavor, Ru.
- rice bran obtained as a by-product in this rice milling process also contains ascorbic acid 2-darcoside and ex, a trehalose, which are the active ingredients of the present invention, and the generation of volatile sulfides is suppressed.
- a trehalose which are the active ingredients of the present invention
- its storage stability is also good, raw materials for pickles or rice bran bed, raw materials for rice bran oil, and as it is. Again Can be advantageously used as a raw material for blended feeds, etc.
- Wheat flour 140 parts by weight, butter 90 parts by weight, chocolate 115 parts by weight, darau monosaccharide 360 parts by weight, whole egg 200 parts by weight, almond 200 parts by weight, powdered volatile prepared by the method of Example 3 Cookies were produced by a conventional method using 0.1 part by mass of an inhibitor for the formation of volatile sulfides. Even after storage of this product at room temperature for 3 months, the formation of volatile sulfides is suppressed, and furthermore, volatile aldehydes, volatile amines and diones from chocolate that are produced by acid degradation of lipids. Since the production of volatile substances such as these is also suppressed, the flavor immediately after production is well maintained.
- Macrogonore (400) 450 parts by mass
- the above component A was mixed and stirred in a vacuum, and this was mixed with component B to obtain an ointment for treating wounds having appropriate elongation and adhesion. Apply this product directly to the wound surface where the formation of volatile sulfides and aldehydes is suppressed and it is easy to apply after use, or it is applied to the affected area. Can treat injuries such as cuts, abrasions, burns, athlete's foot, moistness, and flooring.
- component A was heated and dissolved, and component B was added thereto, emulsified with a homogenizer, an appropriate amount of a fragrance was added and mixed with stirring to produce a cream.
- This product not only suppresses the generation of volatile sulfur compounds, but also suppresses the generation of volatile aldehydes and volatile amines, and maintains high quality with no discoloration or off-flavour.
- Whitening agent In addition, this product can be advantageously used for the prevention of skin irritation and itching, as well as for the treatment and prevention of pigmentation diseases such as spots, buckwheat and sunburn. In addition, it is a cream that has no sticky feeling even when applied to the skin and has an excellent feeling of use.
- the present invention provides a volatile sulfide production inhibitor containing ascorbic acid 2-darcoside as an active ingredient, and the inhibitor is added to the composition.
- This is a method for suppressing the generation of substances.
- ascorbic acid 2-darcoside is a safe substance that can exert the function of vitamin C in vivo when taken orally or parenterally, thus suppressing the formation of volatile sulfides according to the present invention.
- fields of use of the agent and the method for suppressing the generation of volatile sulfides using the agent including food and drink, cosmetics, quasi drugs, pharmaceuticals, feed, feed, and pet food.
- the present invention is an invention that exhibits such remarkable effects, and the industrial contribution is a significant invention.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020147031015A KR101571058B1 (ko) | 2006-02-22 | 2007-02-21 | 휘발성 황화물류의 생성 억제제와 이것을 이용하는 휘발성 황화물류의 생성 억제 방법 |
| EP07714673.6A EP2000036B1 (en) | 2006-02-22 | 2007-02-21 | Method for inhibiting the production of volatile sulfide incorporating the inhibitor into a composition |
| US12/280,470 US8343951B2 (en) | 2006-02-22 | 2007-02-21 | Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
| JP2008501734A JP5145211B2 (ja) | 2006-02-22 | 2007-02-21 | 揮発性硫化物類の生成抑制剤とこれを利用する揮発性硫化物類の生成抑制方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006-045941 | 2006-02-22 | ||
| JP2006045941 | 2006-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2007097357A1 true WO2007097357A1 (ja) | 2007-08-30 |
Family
ID=38437396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2007/053173 Ceased WO2007097357A1 (ja) | 2006-02-22 | 2007-02-21 | 揮発性硫化物類の生成抑制剤とこれを利用する揮発性硫化物類の生成抑制方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8343951B2 (ja) |
| EP (1) | EP2000036B1 (ja) |
| JP (1) | JP5145211B2 (ja) |
| KR (3) | KR20080112210A (ja) |
| WO (1) | WO2007097357A1 (ja) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013065705A1 (ja) * | 2011-10-31 | 2013-05-10 | 興和株式会社 | 粉末化粧料 |
| WO2015118626A1 (ja) * | 2014-02-05 | 2015-08-13 | 株式会社マンダム | 体臭抑制剤 |
| JP2019178073A (ja) * | 2018-03-30 | 2019-10-17 | カーリットホールディングス株式会社 | 含硫アミノ酸の塩を含む固形組成物、その製造方法及びその用途 |
| CN113136406A (zh) * | 2021-04-21 | 2021-07-20 | 云南萱嘉生物技术有限公司 | 一种高效制备2-O-α-D-葡萄糖基-L-抗坏血酸的方法 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110584045A (zh) * | 2016-10-13 | 2019-12-20 | 四川省安科技术咨询有限公司 | 一种榨菜生产中抑制硫化氢产生的方法 |
| KR20240157026A (ko) * | 2022-02-01 | 2024-10-31 | 이나바 쇼쿠힝 가부시키가이샤 | 동물용의 의약 또는 식품 조성물 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03135992A (ja) * | 1989-10-21 | 1991-06-10 | Hayashibara Biochem Lab Inc | 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途 |
| JPH1084866A (ja) * | 1996-09-13 | 1998-04-07 | Kankoku Shokuhin Kaihatsu Kenkyuin | 乳製品の酸化安定性向上方法 |
| WO2004047559A1 (ja) * | 2002-11-27 | 2004-06-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | アクリルアミドの生成抑制方法とその用途 |
| WO2004060077A1 (ja) * | 2002-12-27 | 2004-07-22 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 不快味及び/又は不快臭の低減方法 |
| JP2005060237A (ja) * | 2003-08-11 | 2005-03-10 | Shiseido Co Ltd | パック化粧料 |
| JP2005239655A (ja) * | 2004-02-27 | 2005-09-08 | Nippon Zettoc Co Ltd | 口腔用組成物 |
| JP2006094856A (ja) * | 2004-09-03 | 2006-04-13 | Hayashibara Biochem Lab Inc | 乳加熱臭の生成抑制方法とその用途 |
| JP2006188672A (ja) | 2004-12-06 | 2006-07-20 | Hayashibara Biochem Lab Inc | ラジカル生成抑制剤 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53135925A (en) * | 1976-08-05 | 1978-11-28 | Mitsubishi Gas Chem Co Inc | Decomposition of microbial cells |
| DE60100642T2 (de) * | 2000-06-08 | 2004-06-17 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Verfahren zur Herstellung eines Produktes mit einem hohen Gehalt an 2-O-Alpha-D-Glucopyranosyl-L-ascorbicsäure |
| TWI312369B (en) | 2000-08-01 | 2009-07-21 | Hayashibara Biochem Lab | A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof |
| JPWO2004020552A1 (ja) * | 2002-08-30 | 2005-12-15 | 株式会社林原生物化学研究所 | ラジカル反応抑制剤及びラジカル反応抑制方法並びにその用途 |
| WO2004056216A1 (ja) | 2002-12-19 | 2004-07-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 組成物における水分の変動を抑制する方法とその用途 |
| CN1969032B (zh) * | 2003-02-13 | 2010-12-29 | 株式会社林原生物化学研究所 | 抑制挥发性醛类的产生和/或脂肪酸类的分解的方法及其用途 |
| JP2005013227A (ja) * | 2003-06-06 | 2005-01-20 | Hayashibara Biochem Lab Inc | 加工品の品質保持方法 |
| JP4568035B2 (ja) | 2003-08-28 | 2010-10-27 | 株式会社林原生物化学研究所 | 環状マルトシルマルトース及び環状マルトシルマルトース生成酵素とそれらの製造方法並びに用途 |
| JP2005117958A (ja) * | 2003-10-16 | 2005-05-12 | Nippon Suisan Kaisha Ltd | 硫化水素臭が抑制されたタンパク質食品素材および硫化水素臭の抑制方法 |
| WO2006022174A1 (ja) | 2004-08-24 | 2006-03-02 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | アスコルビン酸2-グルコシドを有効成分とする褐変抑制剤とこれを利用する褐変抑制方法 |
-
2007
- 2007-02-21 WO PCT/JP2007/053173 patent/WO2007097357A1/ja not_active Ceased
- 2007-02-21 KR KR1020087020982A patent/KR20080112210A/ko not_active Ceased
- 2007-02-21 KR KR1020147031015A patent/KR101571058B1/ko not_active Expired - Fee Related
- 2007-02-21 US US12/280,470 patent/US8343951B2/en not_active Expired - Fee Related
- 2007-02-21 JP JP2008501734A patent/JP5145211B2/ja active Active
- 2007-02-21 EP EP07714673.6A patent/EP2000036B1/en not_active Ceased
- 2007-02-21 KR KR1020127009233A patent/KR20120054647A/ko not_active Ceased
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03135992A (ja) * | 1989-10-21 | 1991-06-10 | Hayashibara Biochem Lab Inc | 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途 |
| JPH1084866A (ja) * | 1996-09-13 | 1998-04-07 | Kankoku Shokuhin Kaihatsu Kenkyuin | 乳製品の酸化安定性向上方法 |
| WO2004047559A1 (ja) * | 2002-11-27 | 2004-06-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | アクリルアミドの生成抑制方法とその用途 |
| WO2004060077A1 (ja) * | 2002-12-27 | 2004-07-22 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 不快味及び/又は不快臭の低減方法 |
| JP2005060237A (ja) * | 2003-08-11 | 2005-03-10 | Shiseido Co Ltd | パック化粧料 |
| JP2005239655A (ja) * | 2004-02-27 | 2005-09-08 | Nippon Zettoc Co Ltd | 口腔用組成物 |
| JP2006094856A (ja) * | 2004-09-03 | 2006-04-13 | Hayashibara Biochem Lab Inc | 乳加熱臭の生成抑制方法とその用途 |
| JP2006188672A (ja) | 2004-12-06 | 2006-07-20 | Hayashibara Biochem Lab Inc | ラジカル生成抑制剤 |
Non-Patent Citations (7)
| Title |
|---|
| AGA H.: "Tokushu Kinosei Shokuhin no Kaihatsu ni Mukete L-Ascrobic Acid 2-Glucoside no Kinosei", KAGAKU TO KOGYO, vol. 79, no. 7, 2005, pages 303 - 309, XP003017299 * |
| JUNG M.Y. ET AL.: "Singlet Oxygen and ascorbic Acid Effects on Dimethyl Disulfide and Off-Flavor in Skim Milk Exposed to Light", JOURNAL OF FOOD SCIENCE, vol. 63, no. 3, 1998, pages 408 - 412, XP003017298 * |
| KUROSE M. ET AL.: "Ascorbic Acid 2-Glucoside no Shuki Yokusei Sayo", JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY TAIKAI KOENSHU, vol. 53RD, 28 August 2006 (2006-08-28), pages 119, XP003017297 * |
| MITSUZUMI H.: "Shinki Shitei Tenbakutsu L-Ascorbic Acid 2-Glucoside no Tokusei to Yoto", FFI JOURNAL, vol. 211, no. 5, May 2006 (2006-05-01), pages 435 - 444, XP003017301 * |
| NAGATA H. ET AL.: "Suisan Kanzume no Kan Naimen Kokuhen no Boshi (Prevention of Blackening of Internal Can Wall of Canned Fishery Products)", REPORT OF TOYO JUNIOR COLLEGE OF FOOD TECHNOLOGY AND TOYO INSTITUTE OF FOOD TECHNOLOGY, no. 17, 1987, pages 11 - 18, XP003017300 * |
| See also references of EP2000036A4 |
| TAKAHATA H.: "San Tenka ni yoru Kyabetsu no Kanetsushu no Yokusei to Kakohin eno Oyo", GUNMAKEN NOGYO SHIKENJO KENKYU HOKOKU, no. 7, 2001, pages 49 - 56, XP003017302 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013065705A1 (ja) * | 2011-10-31 | 2013-05-10 | 興和株式会社 | 粉末化粧料 |
| WO2015118626A1 (ja) * | 2014-02-05 | 2015-08-13 | 株式会社マンダム | 体臭抑制剤 |
| JP2019178073A (ja) * | 2018-03-30 | 2019-10-17 | カーリットホールディングス株式会社 | 含硫アミノ酸の塩を含む固形組成物、その製造方法及びその用途 |
| CN113136406A (zh) * | 2021-04-21 | 2021-07-20 | 云南萱嘉生物技术有限公司 | 一种高效制备2-O-α-D-葡萄糖基-L-抗坏血酸的方法 |
| CN113136406B (zh) * | 2021-04-21 | 2023-07-28 | 云南萱嘉生物技术有限公司 | 一种高效制备2-O-α-D-葡萄糖基-L-抗坏血酸的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080112210A (ko) | 2008-12-24 |
| EP2000036A9 (en) | 2009-03-11 |
| EP2000036B1 (en) | 2017-11-08 |
| KR20140147120A (ko) | 2014-12-29 |
| JP5145211B2 (ja) | 2013-02-13 |
| EP2000036A2 (en) | 2008-12-10 |
| JPWO2007097357A1 (ja) | 2009-07-16 |
| EP2000036A4 (en) | 2012-01-18 |
| KR101571058B1 (ko) | 2015-11-23 |
| US20090018217A1 (en) | 2009-01-15 |
| KR20120054647A (ko) | 2012-05-30 |
| US8343951B2 (en) | 2013-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101095258B1 (ko) | 조성물에 있어서의 수분의 변동을 억제하는 방법과 그 용도 | |
| JP4964326B2 (ja) | スクラロースを含有する組成物及びその応用 | |
| KR101007790B1 (ko) | 트레할로오스 또는 말티톨과 금속 이온 화합물과의 회합물(會合物) | |
| JP5876205B2 (ja) | D−ソルボースからなる甘味料におけるd−ソルボースの甘味の不足や、甘味の持続を改良する方法 | |
| EP1588627A1 (en) | Method of reducing unpleasant taste and/or unpleasant odor | |
| KR101075696B1 (ko) | 휘발성 알데히드류의 생성 및/또는 지방산류의 분해를 억제하는 방법과 그 용도 | |
| JP5145211B2 (ja) | 揮発性硫化物類の生成抑制剤とこれを利用する揮発性硫化物類の生成抑制方法 | |
| WO2006022174A1 (ja) | アスコルビン酸2-グルコシドを有効成分とする褐変抑制剤とこれを利用する褐変抑制方法 | |
| WO2004020552A1 (ja) | ラジカル反応抑制剤及びラジカル反応抑制方法並びにその用途 | |
| JPWO2004076602A1 (ja) | 脂質膜を構成している脂質の分解抑制方法及びその用途 | |
| JP7217089B2 (ja) | 血糖値上昇抑制剤及びこれを含んでなる経口組成物 | |
| JP2010265215A (ja) | メチオニナーゼ阻害剤 | |
| JP2005013227A (ja) | 加工品の品質保持方法 | |
| JP3944116B2 (ja) | 鉄臭味抑制剤 | |
| JP2001017138A (ja) | 食品用保存剤および食品の保存方法 | |
| JPH069419A (ja) | マツエキスの嗜好性改善方法およびこの方法により得られる経口摂取物 | |
| WO2006115153A1 (ja) | 肌状態改善作用を有する食品組成物 | |
| JP5943516B2 (ja) | D−ソルボースを有効成分とする生体機能改善用甘味料 | |
| WO1999043219A1 (en) | Ginkgo leaf extract compositions and foods containing the same | |
| JPWO1999043219A1 (ja) | イチョウ葉抽出組成物、及び当該組成物含有食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2008501734 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 12280470 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| REEP | Request for entry into the european phase |
Ref document number: 2007714673 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007714673 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1020127009233 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1020147031015 Country of ref document: KR |
